Vivos Therapeutics Ownership
| VVOS Stock | USD 3.51 0.02 0.57% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Vivos |
Vivos Stock Ownership Analysis
About 14.0% of the company outstanding shares are owned by institutional investors. The book value of Vivos Therapeutics was at this time reported as 1.61. The company recorded a loss per share of 4.99. Vivos Therapeutics had not issued any dividends in recent years. The entity had 1:25 split on the 27th of October 2023. Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea , and snoring in adults. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado. Vivos Therapeutics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 165 people. For more information please call the company at 844 672 4357 or visit https://www.vivos.com.Vivos Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vivos Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vivos Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vivos Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vivos Therapeutics Outstanding Bonds
Vivos Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vivos Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vivos bonds can be classified according to their maturity, which is the date when Vivos Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| VMWARE INC 39 Corp BondUS928563AC98 | View | |
| VMW 22 15 AUG 31 Corp BondUS928563AL97 | View | |
| VODAFONE GROUP PLC Corp BondUS92857WAB63 | View | |
| VMW 14 15 AUG 26 Corp BondUS928563AJ42 | View | |
| VMW 18 15 AUG 28 Corp BondUS928563AK15 | View | |
| VMWARE INC Corp BondUS928563AF20 | View | |
| VMWARE INC Corp BondUS928563AD71 | View | |
| VODAFONE GROUP PLC Corp BondUS92857WAQ33 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.